Missouri
Missouri
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
In Your State
Economic Impact In Your State: Missouri
Economic Impact
$26.6B
Total output supported by biopharmaceutical sector
$1.5B
Tax Revenue Generated
86,066
Total Jobs
17,141
Direct Jobs
970
Total Clinical Trials
$354 million
Invested in Clinical Trials
18,953
Total Economic Impact of Clinical Trial Investments
$981.1 million
Invested in Clinical Trials
Programs and Initiatives in Your State: Missouri
State programs and initiatives to promote biopharmaceutical industry development
- Accelerating Innovation, Commercialization & Entrepreneurial Development
- Building Research Capacity and/or R&D Infrastructure
- STEM Education & Workforce Development
- Targeted Strategies
- Venture Financing